BMS-791826
- Generic Name
- BMS-791826
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C28H26FN5O3S
- CAS Number
- 1008116-73-1
- Unique Ingredient Identifier
- 60BN6CDL0K
- Background
BMS-791826 is under investigation in clinical trial NCT03198013 (A Study of Pharmacokinetics (PK) and Pharmacodynamics (PD) in Relation to Prednisolone in Healthy Males).
- Associated Conditions
- -
- Associated Therapies
- -
A Study of Pharmacokinetics (PK) and Pharmacodynamics (PD) in Relation to Prednisolone in Healthy Males
- First Posted Date
- 2017-06-23
- Last Posted Date
- 2020-06-09
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 120
- Registration Number
- NCT03198013
- Locations
- 🇦🇺
Local Institution, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath